Advising on regulatory, public policy and legal strategy questions in the German healthcare arena as well as in the rest of the European Union, our partners offer healthcare clients a full-service approach to tackling questions of public law, privacy, transactional, licensing and other types of law, as well as public policy and legal strategy advice.

Our EU and German healthcare practice advises on regulatory, public policy and legal strategy, as well as on antitrust, public procurement, privacy, transactional and licensing matters both in Germany and in the rest of the European Union. We provide legal know-how, technology knowledge, industry insight and internationally oriented advice from a commercial perspective. Our approach also considers the public sector, including in niche matters of public law. JUVE nominated WilmerHale as the “Law Firm of the Year for Regulated Industries” in Germany particularly because of our healthcare and pharmaceutical industry practice.

We have advised on the inclusion of innovative medical devices and future-orientated e-health solutions in public reimbursement schemes, and have assisted with tender procedures, negotiations and litigation concerning agreements between healthcare funds and pharmaceutical companies, associations of physicians and other healthcare providers.

Clients also regularly seek our counsel on the reforms of the public healthcare system in Germany and other major EU member states. We help them overcome regulatory and legislative obstacles when launching new products, and enable them to benefit from initiatives such as the introduction of e-health systems. In addition, we have handled a broad range of complex regulatory and legislative issues and new directives and regulations on the EU level in the field of health, safety and product standards applied to life sciences companies.